Position
Chief Development Officer
Company
GH Research PLC
DublinBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
GH Research PLC has announced the appointment of Vanina Popova, MD, as Chief Development Officer. She will lead the clinical development of GH001 as the company advances its pivotal programs in treatment-resistant depression and postpartum depression.
Quick answer
GH Research PLC Appoints Vanina Popova as Chief Development Officer (November 13, 2026). GH Research PLC is based in Dublin, Dublin, Ireland.
- Who is the new Chief Development Officer at GH Research PLC?
- GH Research PLC named Vanina Popova Chief Development Officer, announced November 13, 2026.
- What did GH Research PLC announce on November 13, 2026?
- GH Research PLC has announced the appointment of Vanina Popova, MD, as Chief Development Officer. She will lead the clinical development of GH001 as the company advances its pivotal programs in treatment-resistant depression and postpartum depression.
- What does GH Research PLC do?
- GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression.
- Where is GH Research PLC based?
- GH Research PLC is based in Dublin, Dublin, Ireland.
- Which similar companies made leadership changes around the same time?
- Nurix Therapeutics (November 12, 2026), Pfizer (November 5, 2026), Alnylam Pharmaceuticals (November 5, 2026) and AbbVie Inc. (November 2, 2026) also announced leadership changes within 45 days of GH Research PLC.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer (November 12, 2026)
- Pfizer Appoints Cecile Guegan as CFO and Omnicom Health Names Tom Schwenger as CEO (November 5, 2026)
- Alnylam Pharmaceuticals Announces Departure of Executive Vice President (November 5, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- Cantargia AB Appoints Monic Stuart as Chief Medical Officer (October 26, 2026)
Who to call at GH Research PLC, and when
A new leader at GH Research PLC brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day GH Research PLC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GH Research PLC, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GH Research PLC. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GH Research PLC changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GH Research PLC changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.